Pharmaceutical Technology

NOVEMBER 7, 2022

The next most difficult place to fill these roles was found to be North America, while the Middle East and Africa was in third place. On a regional level, these roles were hardest to fill in Europe, with related jobs that were taken offline in Q3 2022 having been online for an average of 42.8

Pharmaceutical 84

Pharmaceutical Recruitment Marketing 84

Pharmaceutical Technology

DECEMBER 5, 2022

Collectively, cannabinoid receptors (CB1 and CB2) are currently the most popular targets in preclinical stage of development, with 391 drugs tagged in total. In Asia, Africa and the Middle East, cannabinoid-based drugs are mostly illegal and continue to present a major regulatory obstacle.

Medical 98

Medical Specialization Marketing Leads 98

Pharmaceutical Technology

JULY 8, 2022

At the opposite end of the scale, jobs were filled fastest in the Middle East and Africa, with adverts taken offline after 12 days on average. The next most difficult place to fill these roles was found to be Asia-Pacific, while North America was in third place. more time on average compared to similar jobs across the entire jobs market.

Pharma 59

Pharma Recruitment Pharmaceutical Marketing 59

Pharmaceutical Technology

DECEMBER 15, 2022

The Cardiomyopathies: 68-Market Analysis and Sales Forecast report covers a total of 68 markets across Africa, Asia-Pacific (APAC), Europe, Latin America (LATAM), the Middle East and North America. The second highest contributing market is APAC, generating 33.2% of global cardiomyopathies sales in 2021 and 31.2%

Marketing 52

Marketing Sales Healthcare Healthcare 52

Pharmaceutical Technology

MARCH 17, 2023

In some cases, she said, “[drug] innovation would have been otherwise hindered by their price tag alone”. Watt explained that for newer, first-in-class drugs these types of agreements can also give healthcare systems safety in their decisions to approve certain drugs. Click here to watch this webinar and access the presentation.

Marketing 102

Marketing Pharma Pharmaceutical Healthcare 102

Pharmaceutical Technology

NOVEMBER 30, 2022

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. South Africa. Novo Nordisk is another company leading the charge in this field. In a Phase II study, CagriSema achieved a numerically higher body weight reduction of 15.6%

Medical 105

Medical Manufacturing Insurance Side effects 105

Pharmaceutical Technology

NOVEMBER 30, 2022

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. South Africa. Novo Nordisk is another company leading the charge in this field. In a Phase II study, CagriSema achieved a numerically higher body weight reduction of 15.6%

Medical 98

Medical Manufacturing Insurance Side effects 98